BTX-A ( DrugBank: BTX-A )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-INR-17012013	2017-09-01	2017-07-17	Clinical study of botulinum toxin type A in the treatment of depressive symptoms in patients with Pa ...	Clinical study of botulinum toxin type A in the treatment of depressive symptoms in patients with Pa ...	Parkinson‘s disease, Depression	BTX-A:BOTOX Allergan;Placebo:0.9% Sodium Chloride Injection;	Shanghai Tongji Hospital, Tongji University	NULL	Pending	18	80	Both	BTX-A:40;Placebo:40;		China
2	NCT01421719 (ClinicalTrials.gov)	February 2009	19/8/2011	Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's ...	Onabotulinum Toxin Type A (BTX-A) For Treatment of Neurogenic Overactive Bladder Due to Parkinson's ...	Parkinson's Disease;Neurogenic Bladder;Urinary Incontinence;Clostridium Botulinum Toxin Adverse Reac ...	Drug: Cystoscopic injection of Botox into the urinary bladder	Stanford University	Allergan	Completed	50 Years	85 Years	All	20	Phase 4	United States

First Previous1Next Last